United StatesBreaking News

Jeffrey Rosenberg, BlackRock Portfolio Manager of the iShares Systematic Alternatives Active ETF, talks about the books he is reading this summer. He speaks to Tom Keene and Scarlet Fu in New York on June 2 at a Bloomberg subscribers only event for the launch of Bloomberg Money.

Christina Minnis, global head of the alternatives origination group at Goldman Sachs, says lines are blurring between different businesses, noting that businesses such as structured products, investment-grade debt and leveraged finance sit on one floor at Goldman Sachs. She speaks at the Bloomberg Global Credit Forum in New York.

Glendon Capital co-founder Holly Kim explains why the private credit industry stands to see a big "backlog of defaults" away from any economic dislocations or any other inflation-related economic inputs. She speaks at the Bloomberg Global Credit Forum in New York.

Oil rose for a third day as a fresh exchange of strikes between the US and Iran cast doubt on the prospects of a peace deal that would reopen the Strait of Hormuz. Leslie Palti-Guzman, founder at Energy Vista, gives an update on the outlook for oil and natural gas prices amid the war in Iran.

Ares Management co-founder and CEO Michael Arougheti says the private credit market remains strong and the recent stress in the private credit market is tied to private equity. He speaks with Dani Burger at the Forbes Iconoclast Summit in New York.

GitLab (NASDAQ:GTLB) has confirmed the layoff of approximately 350 employees, representing 14% of its workforce, as the company implements a restructuring plan designed to align its operations with the evolving demands of artificial intelligence.

A renewed advance in oil sent stocks lower as bond yields rose on concern that an escalation of hostilities between the US and Iran will hinder prospects for a peace deal. As equities fell from all-time highs, the S&P 500 snapped a nine-day winning streak. Tech shares led losses, with a closely watched ETF tracking software firms dropping 3.5%. Dean Curnutt, founder at Macro Risk Advisors, discusses how the markets are reacting to geopolitical tensions and AI investment interest.

Bitcoin's selloff extended into Wednesday after Strategy Inc.'s sale of a tiny portion of its massive cryptocurrency stockpile rattled sentiment and widened the token's divergence from record-setting technology shares. Jim Ferraioli, Director of Digital Currencies Research and Strategy at Charles Schwab, discusses Bitcoin's latest moves and Charles Schwab's report on mining economics and digital asset outlook.

On this episode of Stock Movers with John Tucker: - Macy's (M) shares are on the move after it lifted its sales outlook for the year, a sign that the company's focus on growing its luxury business and improving its assortment is paying off. - GameStop (GME) shares are climbing after the video-game retailer reported a record quarterly profit driven by its collectibles business. Sales overall climbed 14% to $835.3 million. Net income of $389.6 million was the highest ever for a quarter in the company's history, GameStop said in a regulatory filing Tuesday. - Palo Alto (PANW) shares are dropping as the security software company reported results following a 61% year-to-date rally. The company reported third-quarter results that beat the average analyst expectation and raised its full-year forecast for key metrics, but failed to meet elevated buyside expectations.

Ares Management co-founder and CEO Michael Arougheti says the recent stress in the private credit market is tied to private equity. He speaks with Dani Burger at the Forbes Iconoclast Summit in New York.

Ellen Zentner, Morgan Stanley Wealth Management chief economic strategist, says recent economic data show the US consumer is "flat" and the labor market is "stagnant" during an interview with Matt Miller on "Bloomberg Open Interest."

Eli Lilly and Company (NYSE:LLY) has announced a significant research and licensing collaboration with Ascidian Therapeutics aimed at developing novel treatments for inherited kidney diseases.